A space for sharing and discussing news related to global current events, technology, and society.
69388 Members
We'll be adding more communities soon!
© 2020 Relevant Protocols Inc.
A space for sharing and discussing news related to global current events, technology, and society.
69388 Members
We'll be adding more communities soon!
© 2020 Relevant Protocols Inc.
Relevant
Hot
New
Spam
Relevant
Hot
New
Spam
0
116
0
116
CNN: Biden administration secures 20 million courses of Covid-19 antiviral pill. >"The Biden administration has secured the purchase of 20 _...Read More_
CNN: Biden administration secures 20 million courses of Covid-19 antiviral pill. >"The Biden administration has secured the purchase of 20 _...Read More_
0
5.2
0
5.2
>"Sanofi and GlaxoSmithKline still expect phase 3 trial results for their COVID-19 vaccine in the first quarter of 2022. Researchers in England are looking to find combinations of existing antivirals that can fight the virus. Plus more."
>"Sanofi and GlaxoSmithKline still expect phase 3 trial results for their COVID-19 vaccine in the first quarter of 2022. Researchers in England are looking to find combinations of existing antivirals that can fight the virus. Plus more."
0
63.4
0
63.4
0
114
0
114
Federal regulators Friday approved the use of the antiviral drug remdesivir for covid-19 outpatients at high risk of being hospitalized, providing a new treatment option for doctors struggling with shortages of effective drugs to counter _...Read More_
Federal regulators Friday approved the use of the antiviral drug remdesivir for covid-19 outpatients at high risk of being hospitalized, providing a new treatment option for doctors struggling with shortages of effective drugs to counter _...Read More_
0
220
0
220
In December, Canada ordered one million treatment courses of Paxlovid, manufactured by Pfizer, and has received a shipment of more than 30,000 treatment courses, said Jean-Yves Duclos, minister of health. He said another 120,000 Paxlovid _...Read More_
In December, Canada ordered one million treatment courses of Paxlovid, manufactured by Pfizer, and has received a shipment of more than 30,000 treatment courses, said Jean-Yves Duclos, minister of health. He said another 120,000 Paxlovid _...Read More_
0
4.5K
0
4.5K
0
209
0
209
>"Molnupiravir’s approval comes a day after the FDA cleared a more effective competing antiviral pill from Pfizer."
>"Molnupiravir’s approval comes a day after the FDA cleared a more effective competing antiviral pill from Pfizer."
0
32.5
0
32.5
>"The US Food and Drug Administration on Thursday authorized Merck's antiviral pill, molnupiravir, to treat Covid-19 "for the treatment of mild-to-moderate _...Read More_
>"The US Food and Drug Administration on Thursday authorized Merck's antiviral pill, molnupiravir, to treat Covid-19 "for the treatment of mild-to-moderate _...Read More_
0
539
0
539
"The U.S. on Thursday authorized Merck & Co's antiviral pill for COVID-19 for certain high-risk adult patients, a day after giving a broader go-ahead to a similar but more effective treatment from Pfizer Inc ."
"The U.S. on Thursday authorized Merck & Co's antiviral pill for COVID-19 for certain high-risk adult patients, a day after giving a broader go-ahead to a similar but more effective treatment from Pfizer Inc ."
0
33.9
0
33.9
"A total of 562 patients took part in the study over an eight month period.The double-blind, randomized, placebo-controlled trial was meant to evaluate the efficacy and safety of a three-day course of remdesivir in high-risk, _...Read More_
"A total of 562 patients took part in the study over an eight month period.The double-blind, randomized, placebo-controlled trial was meant to evaluate the efficacy and safety of a three-day course of remdesivir in high-risk, _...Read More_
0
969
0
969
Effective at-home antiviral drugs designed to prevent or treat COVID-19 could be key pandemic-fighting tools, especially _...Read More_
Effective at-home antiviral drugs designed to prevent or treat COVID-19 could be key pandemic-fighting tools, especially _...Read More_
0
10K
0
10K
Pfizer and Merck both generated excitement with news they have pills that could help keep people out of the hospital if they catch coronavirus. [https://edition.cnn.com/2021/11/06/health/antiviral-pill-covid-tool/index.html](https://edition.cnn.com/2021/11/06/health/antiviral-pill-covid-tool/index.html)
Pfizer and Merck both generated excitement with news they have pills that could help keep people out of the hospital if they catch coronavirus. [https://edition.cnn.com/2021/11/06/health/antiviral-pill-covid-tool/index.html](https://edition.cnn.com/2021/11/06/health/antiviral-pill-covid-tool/index.html)
0
431
0
431
"The UK medicines regulator has become the first in the world to approve an oral antiviral pill for Covid in a move that _...Read More_
"The UK medicines regulator has become the first in the world to approve an oral antiviral pill for Covid in a move that _...Read More_